MKMartha Knuth

Martha Knuth

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Martha Knuth has a total of 21 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    From Research to Impact: Assessing a Decade of CDC’s Public Health Science by Topic Area, 2014-2023

    by Joy Ortega, Martha Knuth, Victoria E. Dunkley, Christie Kim, Elissa Meites, Brian B. Yoo, Katlyn Wainwright, Bao-Ping Zhu, Mary G. Reynolds

    Objectives: This study provides an objective, in-depth overview of a large body of science output addressing public health. We apply topic modeling and bibliometric tools to explore the relevance and impact of a decade of CDC-authored publications. Methods: We identified 34,104 scientific publications from 2014-2023 with ≥1 CDC-affiliated author using Science Clips, a CDC library database. We applied a large language modeling framework using BERTopic to publication titles and abstracts to identify public health topic themes. We obtained data from Altmetric, Dimensions, and BMJ Impact Analytics for these publications to bibliometric indicators. We assessed the percent with attention, academic citations, and policy citations using appropriate publication year ranges. We assessed the median Altmetric attention score, median academic citations, and the percent with policy citations for publications by topic area. Results: Of publications from 2014-2020, 95% were cited by academic papers and 52% were cited in clinical guidance or policy. Of publications from 2014-2023, 84% garnered online attention. CDC-authored publications clustered into 46 public health topic themes. Among these, fungal infections had the highest median number of academic citations (36.5), mining safety and health had the highest proportion of papers with policy citations (92.5%), and substance abuse or opioids received the highest median public attention (Altmetric Attention Score = 14). Nearly a third of topics ranked highly (in the top 5) for at least one bibliometric indicator. Conclusions: Publications in this collection addressed an array of public health topic themes and demonstrated resonance within academic and policy arenas as well as with the public. SUMMARY: 1) What is the current understanding of this subject?: Public health science should address strategic priorities and translate to public health impact. CDC’s scientists publish over 3,400 articles per year on average, making it difficult to summarize the breadth of topics covered by these articles and how they affect downstream health outcomes. 2) What does this report add to the literature?: We used cutting-edge large language modeling techniques to categorize CDC-authored publications into 46 topic themes. These topic themes span both infectious and non-infectious disease, and cover topics involved in strategic priorities like emergency response. We assess simple indicators like academic citations, policy citations, and media attention by topic area to show that all topic themes have had measurable impact. Across all topic areas, CDC-authored publications are also highly cited in policy and clinical guidance, an indicator of translation to public health impact. 3) What are the implications for public health practice?: Public health research programs can use advances in large language modeling as well as simple indicators of reach and impact to better understand whether their publications address priority topics and translate to improving health outcomes. This overview of CDC research additionally promotes transparency about the activities of the nation’s foremost public health agency.


  • Open Access

    What are our options for mortality data collection and how can they provide HIV-specific information?

    by Carlie L. Sulpizio, Zaena Tessema, Diane Morof, Andrew Boyd, Elfriede Agyemang, Martha Knuth, Danielle Fernandez, Monita Patel, Hammad Ali

    Background: Mortality data are critical for understanding changes in population health, detecting and monitoring diseases, guiding public health responses and evaluating interventions like human immunodeficiency viruses (HIV) prevention and treatment programmes. However, in low- and middle-income countries (LMICs), comprehensive mortality data are often hindered by a high incidence of deaths occurring outside healthcare facilities and the lack of robust data systems, creating a significant knowledge gap. Aim: This article presents methodologies for collecting mortality data, particularly in LMICs, to provide accurate and reliable information on overall and cause-specific mortality, including HIV-related deaths. Setting: This study explore methods that may be useful in LMICs, where mortality data systems are often ad-hoc, sub-national and incomplete. Method: Available methods were examined for collecting mortality data and report on the strengths, weaknesses and resource considerations for each method. Results: The analysis shows that while Civil Registration and Vital Statistics is the gold standard for mortality data collection, its implementation is challenging because of differing priorities of stakeholders, infrastructural and legal barriers. Alternative methods may provide valuable data but may have limitations in coverage and resource allocation. Integrating these methods can enhance understanding of mortality data, including for HIV-related deaths. Conclusion: Implementing a combination of mortality data-collection methods could address gaps in mortality data in LMICs. Tailoring interventions based on these data may improve health outcomes and support HIV epidemic control efforts. Contribution: This study could be used as a resource to ministries of health, national and international public health organisations, researchers and funding bodies as it can assist countries in selecting the mortality surveillance strategy that best fits their HIV epidemic, and available infrastructure and financial resources.


  • Open Access

    Publication and Impact of Preprints Included in the First 100 Editions of the CDC COVID-19 Science Update: Content Analysis

    by Jeremy Otridge, Cynthia L Ogden, Kyle T Bernstein, Martha Knuth, Julie Fishman, John T Brooks

    Background: Preprints are publicly available manuscripts posted to various servers that have not been peer reviewed. Although preprints have existed since 1961, they have gained increased popularity during the COVID-19 pandemic due to the need for immediate, relevant information. Objective: The aim of this study is to evaluate the publication rate and impact of preprints included in the Centers for Disease Control and Prevention (CDC) COVID-19 Science Update and assess the performance of the COVID-19 Science Update team in selecting impactful preprints. Methods: All preprints in the first 100 editions (April 1, 2020, to July 30, 2021) of the Science Update were included in the study. Preprints that were not published were categorized as “unpublished preprints.” Preprints that were subsequently published exist in 2 versions (in a peer-reviewed journal and on the original preprint server), which were analyzed separately and referred to as “peer-reviewed preprint” and “original preprint,” respectively. Time to publish was the time interval between the date on which a preprint was first posted and the date on which it was first available as a peer-reviewed article. Impact was quantified by Altmetric Attention Score and citation count for all available manuscripts on August 6, 2021. Preprints were analyzed by publication status, publication rate, preprint server, and time to publication. Results: Of the 275 preprints included in the CDC COVID-19 Science Update during the study period, most came from three servers: medRxiv (n=201, 73.1%), bioRxiv (n=41, 14.9%), and SSRN (n=25, 9.1%), with 8 (2.9%) coming from other sources. Additionally, 152 (55.3%) were eventually published. The median time to publish was 2.3 (IQR 1.4-3.7). When preprints posted in the last 2.3 months were excluded (to account for the time to publish), the publication rate was 67.8%. Moreover, 76 journals published at least one preprint from the CDC COVID-19 Science Update, and 18 journals published at least three. The median Altmetric Attention Score for unpublished preprints (n=123, 44.7%) was 146 (IQR 22-552) with a median citation count of 2 (IQR 0-8); for original preprints (n=152, 55.2%), these values were 212 (IQR 22-1164) and 14 (IQR 2-40), respectively; for peer-review preprints, these values were 265 (IQR 29-1896) and 19 (IQR 3-101), respectively. Conclusions: Prior studies of COVID-19 preprints found publication rates between 5.4% and 21.1%. Preprints included in the CDC COVID-19 Science Update were published at a higher rate than overall COVID-19 preprints, and those that were ultimately published were published within months and received higher attention scores than unpublished preprints. These findings indicate that the Science Update process for selecting preprints had a high fidelity in terms of their likelihood to be published and their impact. The incorporation of high-quality preprints into the CDC COVID-19 Science Update improves this activity’s capacity to inform meaningful public health decision-making.


  • Open Access

    Publication and Impact of Preprints Included in the First 100 Editions of the CDC COVID-19 Science Update: Content Analysis (Preprint)

    by Jeremy Otridge, Cynthia L Ogden, Kyle T Bernstein, Martha Knuth, Julie Fishman, John T Brooks

    BACKGROUND Preprints are publicly available manuscripts posted to various servers that have not been peer reviewed. Although preprints have existed since 1961, they have gained increased popularity during the COVID-19 pandemic due to the need for immediate, relevant information. OBJECTIVE The aim of this study is to evaluate the publication rate and impact of preprints included in the Centers for Disease Control and Prevention (CDC) COVID-19 Science Update and assess the performance of the COVID-19 Science Update team in selecting impactful preprints. METHODS All preprints in the first 100 editions (April 1, 2020, to July 30, 2021) of the Science Update were included in the study. Preprints that were not published were categorized as “unpublished preprints.” Preprints that were subsequently published exist in 2 versions (in a peer-reviewed journal and on the original preprint server), which were analyzed separately and referred to as “peer-reviewed preprint” and “original preprint,” respectively. Time to publish was the time interval between the date on which a preprint was first posted and the date on which it was first available as a peer-reviewed article. Impact was quantified by Altmetric Attention Score and citation count for all available manuscripts on August 6, 2021. Preprints were analyzed by publication status, publication rate, preprint server, and time to publication. RESULTS Of the 275 preprints included in the CDC COVID-19 Science Update during the study period, most came from three servers: medRxiv (n=201, 73.1%), bioRxiv (n=41, 14.9%), and SSRN (n=25, 9.1%), with 8 (2.9%) coming from other sources. Additionally, 152 (55.3%) were eventually published. The median time to publish was 2.3 (IQR 1.4-3.7). When preprints posted in the last 2.3 months were excluded (to account for the time to publish), the publication rate was 67.8%. Moreover, 76 journals published at least one preprint from the CDC COVID-19 Science Update, and 18 journals published at least three. The median Altmetric Attention Score for unpublished preprints (n=123, 44.7%) was 146 (IQR 22-552) with a median citation count of 2 (IQR 0-8); for original preprints (n=152, 55.2%), these values were 212 (IQR 22-1164) and 14 (IQR 2-40), respectively; for peer-review preprints, these values were 265 (IQR 29-1896) and 19 (IQR 3-101), respectively. CONCLUSIONS Prior studies of COVID-19 preprints found publication rates between 5.4% and 21.1%. Preprints included in the CDC COVID-19 Science Update were published at a higher rate than overall COVID-19 preprints, and those that were ultimately published were published within months and received higher attention scores than unpublished preprints. These findings indicate that the Science Update process for selecting preprints had a high fidelity in terms of their likelihood to be published and their impact. The incorporation of high-quality preprints into the CDC COVID-19 Science Update improves this activity’s capacity to inform meaningful public health decision-making.